CRISPR is a disruptive technology that can be used to edit genes, and was talked about in detail on this weeks IBD podcast with leading fund manager Cathie Wood from ARK Invest.
The three CRISPR stocks mentioned in the video that ARK are building positions in are:
CRSP, EDIT & NTLA - all of which have appeared in the watchlist. A few multiple times over the last three months.
They have all recently broken out into early Stage 2 (see attached charts), but none with any volume increase as yet, and so have struggled to make progress and have started to form secondary bases on top of the breakout level. So watch for the Stage 2 secondary pullback B entry point or a continuation breakout above the recent bases on surging volume.
Disclaimer: For educational purpose only. Not investment advice. Seek professional advice from a financial advisor before making any investing decisions.